Category Archives: Clients
3 reasons Emergence companies should apply for the BioInnovation Challenge
Now in its tenth year, the BioInnovation Challenge (BIC) is a pitching competition for early-stage life sciences companies in Atlantic Canada. BIC was created by BioNova to help ease the transition from research to market and recognize the significant commercialization … Continue reading
Auxly’s Subsidiary Dosecann Enters into Manufacturing and Distribution Agreement with dosist™, an Award-Winning Wellness Company
TORONTO, June 24, 2020 (GLOBE NEWSWIRE) — Auxly Cannabis Group Inc. (TSX.V – XLY) (“Auxly” or the “Company”), a leading consumer packaged goods company in the derivative cannabis products market, is pleased to announce that its wholly-owned subsidiary Dosecann LD … Continue reading
SP Nutraceuticals Launches First Avocado-based Supplement Metavo to Target Insulin Resistance, Support Healthy Metabolism
Metavo contains AvoB, a powerful bioactive discovered by Canadian scientists and known to support healthy metabolism, blood sugar levels and weight in adults SP Nutraceuticals (SP), as part of its mission to build healthy communities through plant-based nutrition backed by … Continue reading
Join us in welcoming Robin Muzzerall, Facility Manager, CAT Victoria-PEI Plant
The Emergence community welcomes Robin Muzzerall as she begins her new role as Facility Manager at the CAT Victoria-PEI Plant. As Facility Manager, Robin will oversee operations of the newly acquired facility in Victoria by the Sea. The recent acquisition … Continue reading
Alpha Cognition Inc. announces granted EU patents and orphan drug designation for its Progranulin platform
Emergence client Alpha Cognition Inc. (ACI) [formerly Neurodyn Cognition], a clinical stage biotherapeutics company, announced today it has been granted two EU patents (EP2249861A1 and EP3009143A1) relating to the treatment of neurodegenerative diseases using progranulin. Additionally, the FDA, has granted … Continue reading
Posted in Clients
Alpha Cognition Inc. Receives FDA/PMDA Regulatory Guidance for Alpha-1062 Alzheimer’s Therapy
April 30, 2020– [Emergence Client] Alpha Cognition Inc. (ACI) [formerly Neurodyn Cognition] today announced that in a pre-Investigational New Drug (Pre-IND) meeting, the U.S. Food and Drug Administration (USFDA) agreed upon a clinical and regulatory pathway for the approval of Alpha-1062, … Continue reading
Auxly’s Subsidiary Dosecann Signs Key Supplier Agreement With Medical Cannabis by Shoppers
Auxly Cannabis Group Inc. (TSX.V – XLY) (“Auxly” or the “Company”), a leading consumer packaged goods company in the derivative cannabis market, is pleased to announce that its wholly-owned subsidiary Dosecann LD Inc. (“Dosecann”) has entered into an agreement with … Continue reading
Auxly Acquires Exclusive Global Rights to Omega-Rich Ahiflower® Seed Oil for Use in Cannabis Products
Two Emergence clients: Dosecann and Nature’s Crops Auxly Cannabis Group Inc. (TSX.V – XLY) (“Auxly” or the “Company”), a leading consumer packaged goods company in the derivative cannabis market, is pleased to announce that its wholly owned subsidiary Dosecann LD … Continue reading
How one P.E.I. company is using chickens to try to detect COVID-19 in humans
Reprinted from CBC Prince Edward Island. The story was also featured on CBC Compass evening TV news program. A Charlottetown biotech company has joined the fight against COVID-19 by creating antibodies that could help detect the presence of the virus … Continue reading
Posted in Clients, COVID-19 News
Emergence Companies respond to the COVID-19 challenge
As essential service staff work long hours and families distance themselves from others by hunkering down in their homes, bioscience companies and their employees are flexing their research, development and manufacturing muscle to help in the fight against COVID-19. Seven … Continue reading
